These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19596928)

  • 1. Preoperative chemoradiotherapy for esophageal cancer: factors associated with clinical response and postoperative complications.
    Morita M; Masuda T; Okada S; Yoshinaga K; Saeki H; Tokunaga E; Endo K; Emi Y; Kakeji Y; Maehara Y
    Anticancer Res; 2009 Jul; 29(7):2555-62. PubMed ID: 19596928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative chemoradiotherapy for esophageal cancer enhances the postoperative systemic inflammatory response.
    Tsujimoto H; Ono S; Chochi K; Sugasawa H; Ichikura T; Mochizuki H
    Jpn J Clin Oncol; 2006 Oct; 36(10):632-7. PubMed ID: 17020895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.
    Nakamura T; Ota M; Hayashi K; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Hepatogastroenterology; 2006; 53(71):705-9. PubMed ID: 17086873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage esophagectomy after definitive chemoradiotherapy for thoracic esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Nishida T; Mori M; Doki Y
    J Surg Oncol; 2009 Nov; 100(6):442-6. PubMed ID: 19653262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative versus postoperative chemoradiotherapy in the trimodality management of esophageal cancer.
    Kim C; Monjazeb AM; Suntharalingam M; Giesinger KR; Blackstock AW
    Clin Adv Hematol Oncol; 2009 May; 7(5):327-333, 342. PubMed ID: 19521322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.
    Lecleire S; Di Fiore F; Antonietti M; Ben-Soussan E; Hochain P; Lerebours E; Michel P; Ducrotté P
    Am J Gastroenterol; 2008 Sep; 103(9):2215-9. PubMed ID: 18844614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High orotate phosphoribosyltransferase gene expression predicts complete response to chemoradiotherapy in patients with squamous cell carcinoma of the esophagus.
    Kajiwara T; Nishina T; Hyodo I; Moriwaki T; Endo S; Nasu J; Hori S; Matsuura B; Hiasa Y; Onji M
    Oncology; 2009; 76(5):342-9. PubMed ID: 19307741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer.
    Di Fiore F; Lecleire S; Pop D; Rigal O; Hamidou H; Paillot B; Ducrotté P; Lerebours E; Michel P
    Am J Gastroenterol; 2007 Nov; 102(11):2557-63. PubMed ID: 17680847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy.
    Kader AS; Lim JT; Berthelet E; Petersen R; Ludgate D; Truong PT
    Am J Clin Oncol; 2007 Oct; 30(5):492-7. PubMed ID: 17921709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
    Kim MK; Kim SB; Ahn JH; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HY; Shin JH; Cho KJ; Ryu JS; Park SI
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):725-34. PubMed ID: 18164836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
    Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
    Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective review of surgery and definitive chemoradiotherapy in patients with squamous cell carcinoma of the thoracic esophagus aged 75 years or older.
    Kosugi S; Sasamoto R; Kanda T; Matsuki A; Hatakeyama K
    Jpn J Clin Oncol; 2009 Jun; 39(6):360-6. PubMed ID: 19389794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior chemoradiotherapy is associated with a higher life-threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer.
    Lecleire S; Di Fiore F; Ben-Soussan E; Antonietti M; Hellot MF; Paillot B; Lerebours E; Ducrotté P; Michel P
    Aliment Pharmacol Ther; 2006 Jun; 23(12):1693-702. PubMed ID: 16817912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive wrapping of the fragile tracheobronchial wall using a flap of latissimus dorsi muscle during esophagectomy after chemoradiotherapy.
    Sato Y; Motoyama S; Maruyama K; Hayashi K; Usami S; Minamiya Y; Saito H; Kitamura M; Saito R; Ogawa J
    Eur Surg Res; 2008; 41(3):279-83. PubMed ID: 18600026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
    Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer.
    Melis M; McLoughlin JM; Dean EM; Siegel EM; Weber JM; Shah N; Kelley ST; Karl RC
    J Surg Res; 2009 May; 153(1):114-20. PubMed ID: 19201421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer.
    Kim MK; Cho KJ; Kwon GY; Park SI; Kim YH; Kim JH; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Kim SB
    Eur J Cancer; 2008 Jan; 44(1):54-60. PubMed ID: 17976974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.